Загрузка...
Practical guidance for using rivaroxaban in patients with atrial fibrillation: balancing benefit and risk
Rivaroxaban is a direct factor Xa inhibitor that is widely available to reduce the risk of stroke or systemic embolism in patients with nonvalvular atrial fibrillation and one or more risk factors for stroke. Rivaroxaban provides practical advantages compared with warfarin and other vitamin K antago...
Сохранить в:
| Главные авторы: | , , , |
|---|---|
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Dove Medical Press
2014
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3956810/ https://ncbi.nlm.nih.gov/pubmed/24648742 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/VHRM.S55246 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|